Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ehninger

Showing results (41-50 of 400) with videos related to

Pageof 40
Sort By:
Der Pathologe|February 28, 2001
[Precancerous risk markers in Helicobacter pylori gastritis]S Miehlke, E Bayerdörffer, G Ehninger, et al.
Bone Marrow Transplantation|January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drugG Ehninger, K Eger, A Stuhler, et al.
Onkologie|August 1, 1985
[Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics]G Ehninger, H Rückle, C Haag, et al.
Deutsche Zahnarztliche Zeitschrift|November 1, 1990
[Severe hard tooth structure decay following full body radiotherapy prior to bone marrow transplantation]S Handtmann, H Hüttemann, W Schulte, et al.
Transplantation|November 1, 1986
HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantationG Pawelec, G Ehninger, H Schmidt, et al.
Cancer Treatment Reports|December 1, 1986
Clinical pharmacology of mitoxantroneG Ehninger, B Proksch, G Heinzel, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomitingH J Lenz, U Schuler, W Hicking, et al.
Klinische Wochenschrift|September 15, 1980
[The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)]G Ehninger, H J Stocker, B Proksch, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 13, 2007
High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparationsS Pursche, O G Ottmann, G Ehninger, et al.
British Journal of Haematology|June 1, 1990
Chronic graft-versus-host disease and HLA-DR4 in the southern German populationG Pawelec, C A Müller, M Haen, et al.
Pageof 40

Showing results (41-50 of 400) with videos related to

Sort By:
Pageof 40
Der Pathologe|February 28, 2001
[Precancerous risk markers in Helicobacter pylori gastritis]S Miehlke, E Bayerdörffer, G Ehninger, et al.
Bone Marrow Transplantation|January 1, 1993
Thalidomide--the need for a new clinical evaluation of an old drugG Ehninger, K Eger, A Stuhler, et al.
Onkologie|August 1, 1985
[Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics]G Ehninger, H Rückle, C Haag, et al.
Deutsche Zahnarztliche Zeitschrift|November 1, 1990
[Severe hard tooth structure decay following full body radiotherapy prior to bone marrow transplantation]S Handtmann, H Hüttemann, W Schulte, et al.
Transplantation|November 1, 1986
HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantationG Pawelec, G Ehninger, H Schmidt, et al.
Cancer Treatment Reports|December 1, 1986
Clinical pharmacology of mitoxantroneG Ehninger, B Proksch, G Heinzel, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomitingH J Lenz, U Schuler, W Hicking, et al.
Klinische Wochenschrift|September 15, 1980
[The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)]G Ehninger, H J Stocker, B Proksch, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 13, 2007
High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparationsS Pursche, O G Ottmann, G Ehninger, et al.
British Journal of Haematology|June 1, 1990
Chronic graft-versus-host disease and HLA-DR4 in the southern German populationG Pawelec, C A Müller, M Haen, et al.
Pageof 40